Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 522815Generated: November 1, 2026

Cesium fluoride → HCID 178461600, compound

https://huagongshe.com/reaction/522815

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCesium fluorideHCID 25953—
ReactantTricyclohexylphosphineHCID 75806—
ReactantPotassium AcetateHCID 517044—
ReactantBis(pinacolato)diboraneHCID 2733548—
Reactant4-chloro-6-fluoro-1H-indoleHCID 24728177—
ReactantHCID 178461599HCID 178461599—
SolventEthyl AcetateHCID 8857—
Solvent1,4-DioxaneHCID 31275—
ProductHCID 178461600HCID 17846160052.1%

Reaction Conditions

Temperature80 °C

Reaction Steps

4-Chloro-6-fluoro-1H-indole (72 mg, 0.42 mmol) was dissolved in 4 mL of dioxane under argon. Bis(pinacolato)diboron (198 mg, 778 μmol), tricyclohexylphospine (19.8 mg, 71 μmol), bis(dibenzylidenacetone)palladium (20.3 mg, 35 μmol), and potassium acetate (104 mg, 1.06 mmol) were added under argon. The reaction was stirred for 24 hours at 80° C. The reaction mixture was cooled to room temperature and diluted with 30 mL of EtOAc. The organic layer was washed with 20 mL of brine, dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was filtered through a column (40 g SiO2; EtOAc/heptane in a gradient from 0/100 to 12/88) to yield a mixture, which was concentrated under reduced pressure, and then dissolved in 2 mL of acetonitrile and 0.2 mL of water under argon. 8-Bromo-2-((S)-3-methylmorpholin-4-yl-)-6-((R)-3-methyl-morpholin-4-yl)-9H-purine (100 mg, 153 μmol) was added, followed by cesium fluoride (25.8 mg, 170 μmol) and tetrakis(triphenylphospine)palladium (26 mg, 23 μmol). The reaction mixture was stirred at 135° C. for 2 hours in a sealed vial. The reaction mixture was cooled to room temperature and diluted with 40 mL of EtOAc. The organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by column chromatography (10 g SiO2; tertbutylmethylether) to give the title compound as a foam (36 mg, 19% over 2 steps).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09334271B2
Source datasetuspto-grants-2016_05
ORD IDord-39fcc2fd6f284e548ab0415ad92aa2e5
Source noteuspto-grants-2016_05